PainChek® provides carers across multiple clinical areas with three important new clinical benefits;
1. The ability to identify the presence of pain, when pain isn’t obvious
2. To quantify the severity level of pain, when pain is obvious, and
3. To monitor the impact of treatment to optimise overall care
How Does PainChek® Do This?
As this video demonstrates, PainChek® uses cameras in smartphones and tablets to capture a brief video of the person, which is analysed in real time using facial recognition software to detect the presence of facial micro-expressions that are indicative of the presence of pain.
This data is then combined with other indicators of pain, such as vocalisations, behaviours and movements captured to calculate a pain severity score. Due to its speed, ease of use and its reproducibility, PainChek® will be able to be used to detect and measure a person’s pain, and then further measurements can be used to monitor the effectiveness of pain management.
What’s Next?
The pain assessment tool has now gained market traction in Australia with over 2,700 clinical pain assessments now complete, and nine clients across twelve Residential Aged Care (RAC) facilities.
In Australia, there are 400,000 people living with dementia in Australia of which 115,000 are within Residential Aged Care (1). At a global level there are 50 Million people living with dementia. While the Australian market has large potential in its own right, Australia is just 2% of the PainChek® global market opportunity and PainChek® continues to plan ahead to enter Europe and other overseas markets in 2019.
